Provectus Biopharmaceuticals Inc. To Commence Series Of Quarterly Conference Calls On Thursday, August 7, 2014

Provectus Biopharmaceuticals, Inc. (NYSE MKT:PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, will begin a series of regular quarterly conference calls to update the market in general and shareholders in particular about developments at the Company. In the future, these calls will coincide with the filing of the Company’s 10-Q and 10-K filings with the Securities and Exchange Commission as appropriate.

Help employers find you! Check out all the jobs and post your resume.